Abstract 2021 marks the 30th anniversary of the original development of the Banff
Classification of Kidney Allograft Pathology, when in August 1991 a group of pathologists …

Abstract Although anti–HLA (Human Leukocyte Antigen) donor-specific antibodies (DSAs)
are commonly measured in clinical practice and their relationship with transplant outcome is …

The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications
of inflammation in areas of interstitial fibrosis and tubular atrophy (i‐IFTA) and its relationship …

The XIII Banff meeting, held in conjunction the Canadian Society of Transplantation in
Vancouver, Canada, reviewed the clinical impact of updates of C4d-negative antibody …

Progress in renal transplantation requires improved understanding and assessment of
rejection and injury. Study of the relationship between gene expression and clinical …

Cells of the innate and adaptive immune systems play a critical role in the host response to
sepsis. Moreover, their accessibility for sampling and their capacity to respond dynamically …

This review outlines the molecular disease states in kidney transplant biopsies as
documented in the development of the Molecular Microscope Diagnostic System (MMDx) …

Urinary levels of CXC motif chemokine 9 (CXCL9) and CXCL10 can noninvasively diagnose
T cell–mediated rejection (TCMR) of renal allografts. However, performance of these …

Background To seek insights into the pathogenesis of chronic active antibody–mediated
rejection (CAMR), we performed mRNA analysis and correlated transcripts with pathologic …

In the context of lung transplant (LT), because of diagnostic difficulties, antibody-mediated
rejection (AMR) remains a matter of debate. We retrospectively analyzed an LT cohort at …